Recce Pharmaceuticals up 6% on new antibiotic production milestone
Recce Pharmaceuticals (ASX:RCE) is trading up more than 6 per cent after producing a 5000-dose batch of its new antibiotic RECCE 327 (R327) under Good Manufacturing Practises (GMP) standards.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
JGY | Ann:Stock code to change to LSJ from 5 October 2022 | 28/09/22 | 0 | 330 | |||
|
|||||||
JGY | Ann:Name change to Laishi Liquor Limited | 16/09/22 | 0 | 443 | |||
|
|||||||
JGY | Ann:Board changes | 16/09/22 | 0 | 316 | |||
|
|||||||
JGY | Ann:Initial interest notice of ZHANG Houyi | 16/09/22 | 0 | 333 | |||
|
|||||||
JGY | Ann:Initial interest notice of Ilmars DRAUDINS | 16/09/22 | 0 | 336 | |||
|
|||||||
JGY | Ann:Initial interest notice of Long Huy LAM (Bill) | 16/09/22 | 0 | 332 | |||
|
|||||||
JGY | Ann:Director's declaration and undertaking of ZHANG Houyi (Price Sensitive) | 16/09/22 | 0 | 377 | |||
|
|||||||
JGY | Ann:Director's declaration and undertaking Ilmars DRAUDINS (Price Sensitive) | 16/09/22 | 0 | 352 | |||
|
See All Discussions